期刊文献+

PCSK9降解ApoER2对ApoE/ApoER2抗炎作用的影响 被引量:1

Effect of ApoER2 degradation by PCSK9 on the anti-inflammatory effect of ApoE/ApoER2
下载PDF
导出
摘要 [目的]探讨前蛋白转化酶枯草溶菌素9(PCSK9)对载脂蛋白E(ApoE)受体2(ApoER2)的降解作用与ApoE/ApoER2抗炎作用之间的关系。[方法]体外培养人脐静脉内皮细胞(HUVEC)和HepG2细胞,采用Western blot和ELISA检测脂多糖(LPS)对HUVEC中Toll样受体(TLR4)、肿瘤坏死因子α(TNF-α)、白细胞介素6(IL-6)和PCSK9表达及分泌的影响;ApoE3对LPS诱导的HUVEC中TNF-α、IL-6、PCSK9和ApoER2表达及分泌的影响;ApoE的三种亚型(ApoE2、ApoE3和ApoE4)对非炎症状态下HUVEC和HepG2细胞中PCSK9及ApoER2表达的影响;PCSK9对HUVEC中ApoER2、TNF-α和IL-6表达及分泌的影响。[结果]Western blot和ELISA检测结果显示,LPS可以上调HUVEC中TLR4、TNF-α、IL-6和PCSK9的表达及分泌。ApoE3抑制LPS诱导的炎症反应,并上调ApoER2的表达及分泌。ApoE的三种亚型(ApoE2、ApoE3和ApoE4)对非炎症状态下HUVEC和HepG2细胞中PCSK9及ApoER2的表达无明显影响。不同剂量(0、0.5、1.0和2.5 mg/L)的人重组PCSK9处理HUVEC 24 h,Western blot和ELISA检测结果显示,PCSK9上调TNF-α、IL-6的表达及分泌,下调ApoER2的表达。[结论]PCSK9通过对ApoER2的降解来拮抗ApoE/ApoER2的抗炎作用。 Aim To investigate the relationship between apolipoprotein E(ApoE)receptor 2(ApoER2)degradation by proprotein convertase subtilisin kexin 9(PCSK9)and the anti-inflammatory effect of ApoE/ApoER2.Methods Human umbilical vein endothelial cells(HUVEC)and HepG2 cells were cultured in vitro,Western blot and ELISA were used to detect the effects of lipopolysaccharide(LPS)on the expression and secretion of Toll-like receptor(TLR4),tumor necrosis factor-α(TNF-α),interleukin-6(IL-6)and PCSK9 in HUVEC;the effects of ApoE3 on the expression and secretion of TNF-α,IL-6,PCSK9 and ApoER2 in HUVEC induced by LPS;the effects of three isoforms of ApoE(ApoE2,ApoE3 and ApoE4)on the expression of PCSK9 and ApoER2 in HUVEC and HepG2 cells under non-inflammatory conditions;and the effects of PCSK9 on the expression and secretion of ApoER2,TNF-αand IL-6 in HUVEC.Results Western blot and ELISA showed that LPS up-regulated the expression and secretion of TLR4,TNF-α,IL-6 and PCSK9 in HUVEC;ApoE3 inhibited LPS-induced inflammatory responses,and up-regulated ApoER2 expression and secretion;the three isoforms of ApoE(ApoE2,ApoE3 and ApoE4)had no effect on the expression of PCSK9 and ApoER2 in HUVEC and HepG2 cells under non-inflammatory conditions.Different doses(0,0.5,1.0 and 2.5 mg/L)of recombinant human PCSK9 were used to treat HUVEC for 24 h,Western blot and ELISA showed that PCSK9 up-regulated the expression and secretion of TNF-αand IL-6,and down-regulated the expression of ApoER2.Conclusion PCSK9 antagonizes the anti-inflammatory effects of ApoE/ApoER2 by degrading ApoER2.
作者 赵伊梦 白雪琴 何俊锋 王萍 刘录山 ZHAO Yimeng;BAI Xueqin;HE Junfeng;WANG Ping;LIU Lushan(Institute of Cardiovascular Disease,University of South China&Key Laboratory for Arteriosclerology of Hunan Province&Human International Scientific and Technological Cooperation Base of Arteriosclerotic Disease,Hengyang,Hunan 421001,China;Changde Wuling District Center for Disease Control and Prevention,Changde,Hunan 415000,China)
出处 《中国动脉硬化杂志》 CAS 2023年第5期375-382,共8页 Chinese Journal of Arteriosclerosis
基金 湖南省自然科学基金项目(2021JJ30596) 湖南省研究生科研创新项目(QL20220217)。
关键词 炎症反应 前蛋白转化酶枯草溶菌素9 载脂蛋白E 载脂蛋白E受体2 inflammation proprotein convertase subtilisin kexin 9 apolipoprotein E apolipoprotein E receptor 2
  • 相关文献

参考文献6

二级参考文献34

  • 1陈春燕,郭晋村,黄卫斌.胰岛素样生长因子结合蛋白4基因对内皮细胞衰老的调节作用[J].中国动脉硬化杂志,2015,23(5):490-494. 被引量:3
  • 2Yamamoto T, Lu C, Ryan RO. A two-step binding model of PCSK9 interaction with the low density lipoprotein receptor[J]. J Siol Chem, 2011, 286(7) : 5 464-470.
  • 3Benjannet S, Saavedra YG, Hamelin J, et al. Effects of the prosegment and pH on the activity of PCSK9 : Evidence for additional processing events [ J]. J Biol Chem, 2010, 285(52) : 40 965-978.
  • 4Poirier S, Mayer G, Benjannet S, et al. The proprotein convertase PCSK9 induces the degradation of low density lipoprotein receptor (LDLR) and its closest family members VLDLR and ApoER2 [ J]. J Biol Chem, 2008, 283 (4) : 2 363-372.
  • 5Lan H, Pang L, Smith MM, et al. Proprotein convertase subtilisin/kexin type 9 (PCSK9) affects gene expression pathways beyond cholesterol metabolism in liver ceils [ J ]. J Cell Physiol, 2010, 224(1) : 273-281.
  • 6Ranheim T, Mattingsdal M, Lindvall JM, et al. Genomewide expression analysis of cells expressing gain of function mutant D374Y-PCSK9 [ J ]. J Cell Physiol, 2008, 217(2) : 459-467.
  • 7Feingold KR, Moser AH, Shigenaga JK, et al. Inflammation stimulates the expression of PCSK9 [ J ]. Biochem Biophys Res Commun, 2008, 374(2) : 341-344.
  • 8Hampton EN, Knuth MW, Li J, et al. The self-inhibited structure of full-length PCSK9 at 1. 9 A reveals structural homology with resistin within the C-terminal domain [ J ]. Proc Natl Acad Sci USA, 2007, 104(37) : 14 604-609.
  • 9Tarkowski A, Bjersing J, Shestakov A, et al. Resistin competes with lipopolysaccharide for binding to toll-like receptor4[J]. J Cell Mol Med, 2010, 14(6B) : 1 419-431.
  • 10Van E M,Atherosclerosis,2001年,154卷,1期,103页

共引文献61

同被引文献3

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部